Naperville, IL -- (SBWIRE) -- 12/23/2014 -- Reportstack, provider of premium market research reports announces the addition of In Vitro Diagnostics Market in India 2014 market report to its offering
Netscribes latest market research report titled In Vitro Diagnostics Market in India 2014 analyses the growth of the market due to improved technology and modern diagnostic tools which provides faster and accurate test results for the patients. The market can be segmented on the basis of the product type and the technology used. The technology market is sub-divided into the following sections such as immunochemistry, molecular diagnostics, hematology, coagulation, microbiology, biochemistry, urinalysis and blood gas and electrolyte. According to product type, the market can be further sub-divided into instruments and reagents.
Driven by factors such as high patient population, rise in the number of hospitals and diagnostic labs and other factors, the IVD market is experiencing a developing phase. The main challenges the market is experiencing are faulty regulations and laboratory without accreditation. Trends such as automation, remote data acquisition and other factors are helping the market to grow. The market is dominated by private player followed by public players. Decentralized testing, increasing automated laboratories, increasing consolidation and demand for early detection of diseases will contribute towards the growth of the market in the following years
1. Piramal Healthcare Ltd.
2. Siemens Ltd.
3. Span Diagnostics Ltd.
1. Agappe Diagnostics Limited
2. Life Technologies India Private Limited
3. BioMrieux India Private Limited
4. Trivitron Healthcare Pvt. Ltd.
5. Transasia Bio-medicals Pvt. Ltd.
6. Beckman Coulter India Pvt. Ltd.
7. Becton Dickinson India Pvt. Ltd.
8. Roche Diagnostics India Pvt. Ltd.
9. Sysmex India Pvt. Ltd.
10. Tulip Diagnostics India Pvt. Ltd.
11. Thermo Fisher Scientific India Pvt. Ltd.
12. Alere Medical Private Limited
Complete report is available